RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

In This Article: BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 7, RBC Capital analyst Brian Abrahams maintained a Buy rating on BioCryst Pharmaceutical Inc. (NASDAQ:BCRX) and set a price target of $13.00. A scientist in a lab coat…